NLRP3 and myopia: Considering the role of NLRP3 activation and inflammation in the progression of myopia, it is reasonable to hypothesize that MCC950 could potentially reduce the inflammatory response associated with myopia by inhibiting the expression of NLRP3, thereby slowing down disease progression.